Literature DB >> 16905117

Parkin affects mitochondrial function and apoptosis in neuronal and myogenic cells.

Yukiko Kuroda1, Takao Mitsui, Makoto Kunishige, Toshio Matsumoto.   

Abstract

We investigated the effect of parkin on mitochondrial function and apoptosis in SH-SY5Y, L6, RD, and COS-1 cells. Wild-type parkin attenuated reactive oxygen species (ROS) production in SH-SY5Y cells and mutant parkin enhanced ROS production in SH-SY5Y and L6 cells. Reactive oxygen intermediates, that were detected in mitochondria, were decreased in cells with overexpression of parkin. Parkin prevented apoptosis and enhanced mitochondrial membrane potentials in SH-SY5Y and L6 cells not in COS-1 cells. Expressions and enzymatic activities of mitochondrial respiratory chain complexes were not uniformly enhanced but those of complex 1 were selectively enhanced. The present results suggest the cell-selective function of parkin, i.e., parkin possesses anti-apoptotic and anti-oxidant function in neuronal or myogenic cells but not in kidney cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16905117     DOI: 10.1016/j.bbrc.2006.06.201

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling.

Authors:  Anna Sandebring; Nodi Dehvari; Monica Perez-Manso; Kelly Jean Thomas; Elena Karpilovski; Mark R Cookson; Richard F Cowburn; Angel Cedazo-Mínguez
Journal:  FEBS J       Date:  2009-08-03       Impact factor: 5.542

Review 2.  Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions.

Authors:  Linnea R Freeman; Jeffrey N Keller
Journal:  Biochim Biophys Acta       Date:  2011-12-20

Review 3.  Parkinson's disease and enhanced inflammatory response.

Authors:  Iva Stojkovska; Brandon M Wagner; Brad E Morrison
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

4.  Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Authors:  Tomás González-Hernández; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Josmar Salas-Hernandez; Javier Castro-Hernandez
Journal:  Front Neuroanat       Date:  2010-10-20       Impact factor: 3.856

5.  Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function.

Authors:  Kenneth M Rosen; Charbel E-H Moussa; Han-Kyu Lee; Pravir Kumar; Tohru Kitada; Gangjian Qin; Qinghao Fu; Henry W Querfurth
Journal:  J Neurosci Res       Date:  2010-01       Impact factor: 4.164

6.  Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis.

Authors:  Sergio E Baranzini; Joanne Wang; Rachel A Gibson; Nicholas Galwey; Yvonne Naegelin; Frederik Barkhof; Ernst-Wilhelm Radue; Raija L P Lindberg; Bernard M G Uitdehaag; Michael R Johnson; Aspasia Angelakopoulou; Leslie Hall; Jill C Richardson; Rab K Prinjha; Achim Gass; Jeroen J G Geurts; Jolijn Kragt; Madeleine Sombekke; Hugo Vrenken; Pamela Qualley; Robin R Lincoln; Refujia Gomez; Stacy J Caillier; Michaela F George; Hourieh Mousavi; Rosa Guerrero; Darin T Okuda; Bruce A C Cree; Ari J Green; Emmanuelle Waubant; Douglas S Goodin; Daniel Pelletier; Paul M Matthews; Stephen L Hauser; Ludwig Kappos; Chris H Polman; Jorge R Oksenberg
Journal:  Hum Mol Genet       Date:  2008-11-14       Impact factor: 6.150

Review 7.  Mitochondrial dynamics in Parkinson's disease.

Authors:  Victor S Van Laar; Sarah B Berman
Journal:  Exp Neurol       Date:  2009-03-28       Impact factor: 5.330

Review 8.  Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications.

Authors:  Jin-Qiang Chen; Patrick R Cammarata; Christopher P Baines; James D Yager
Journal:  Biochim Biophys Acta       Date:  2009-06-23

9.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

10.  Parkin promotes degradation of the mitochondrial pro-apoptotic ARTS protein.

Authors:  Stav Kemeny; Dikla Dery; Yelena Loboda; Marshall Rovner; Tali Lev; Dotan Zuri; John P M Finberg; Sarit Larisch
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.